Solid Biosciences Inc. SEC filings SLDB
Solid Biosciences Inc. has 737 filings in SEC EDGAR's recent list, going back to Aug 4, 2017. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 6, 2026 | — |
| S-3ASR | Automatic shelf registration | Aug 6, 2026 | — |
| 424B7 | Filing | Jun 5, 2026 | — |
| S-3 | Shelf registration | Mar 19, 2026 | — |
| S-3 | Shelf registration | Mar 19, 2026 | — |
| S-8 | Employee stock plan registration | Mar 19, 2026 | — |
| S-8 | Employee stock plan registration | Jun 13, 2025 | — |
| 424B5 | Prospectus supplement | May 15, 2025 | — |
| S-3 | Shelf registration | May 15, 2025 | — |
| S-3 | Shelf registration | Mar 6, 2025 | — |
| S-3 | Shelf registration | Mar 6, 2025 | — |
| S-8 | Employee stock plan registration | Mar 6, 2025 | — |
| 424B5 | Prospectus supplement | Feb 18, 2025 | — |
| FWP | Free writing prospectus | Feb 18, 2025 | — |
| S-8 | Employee stock plan registration | Jun 11, 2024 | — |
| S-3/A | Filing | May 15, 2024 | — |
| S-3 | Shelf registration | Mar 13, 2024 | — |
| S-8 | Employee stock plan registration | Mar 13, 2024 | — |
| S-3 | Shelf registration | Jan 30, 2024 | — |
| S-8 | Employee stock plan registration | Jun 6, 2023 | — |
| 424B5 | Prospectus supplement | Mar 23, 2023 | — |
| S-8 | Employee stock plan registration | Mar 23, 2023 | — |
| S-3 | Shelf registration | Jan 26, 2023 | — |
| S-8 | Employee stock plan registration | Jan 9, 2023 | — |
| S-8 | Employee stock plan registration | Dec 2, 2022 | — |
| S-8 | Employee stock plan registration | Jun 1, 2022 | — |
| S-3 | Shelf registration | Aug 16, 2021 | — |
| S-8 | Employee stock plan registration | Aug 16, 2021 | — |
| 424B5 | Prospectus supplement | Mar 19, 2021 | — |
| 424B5 | Prospectus supplement | Mar 18, 2021 | — |
| S-3 | Shelf registration | Mar 15, 2021 | — |
| S-8 | Employee stock plan registration | Aug 6, 2020 | — |
| 424B3 | Prospectus | Oct 28, 2019 | — |
| S-3/A | Filing | Oct 23, 2019 | — |
| S-3 | Shelf registration | Sep 3, 2019 | — |
| S-3 | Shelf registration | Mar 13, 2019 | — |
| S-8 | Employee stock plan registration | Jan 29, 2018 | — |
| 424B4 | Prospectus | Jan 29, 2018 | — |
| S-1MEF | Filing | Jan 25, 2018 | — |
| FWP | Free writing prospectus | Jan 25, 2018 | — |
| S-1/A | Amended registration statement | Jan 25, 2018 | — |
| S-1/A | Amended registration statement | Jan 24, 2018 | — |
| S-1/A | Amended registration statement | Jan 16, 2018 | — |
| S-1 | Registration statement | Dec 29, 2017 | — |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SLDB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Charlestown, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1707502
- Former names
- Solid Biosciences, LLC (until Jan 25, 2018)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.